Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Cash from Investing Activities: 2009-2024

Historic Cash from Investing Activities for Nutex Health (NUTX) over the last 16 years, with FY2024 value amounting to -$5.6 million.

  • Nutex Health's Cash from Investing Activities fell 1310.86% to -$302000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$234000.0, marking a year-over-year increase of 9220.78%. This contributed to the annual value of -$5.6 million for FY2024, which is 5012.39% up from last year.
  • Latest data reveals that Nutex Health reported Cash from Investing Activities of -$5.6 million as of FY2024, which was up 5012.39% from -$11.2 million recorded in FY2023.
  • Nutex Health's 5-year Cash from Investing Activities high stood at -$4.3 million for FY2022, and its period low was -$61.2 million during FY2020.
  • Over the past 5 years, Nutex Health's median Cash from Investing Activities value was -$11.2 million (recorded in 2023), while the average stood at -$23.9 million.
  • Per our database at Business Quant, Nutex Health's Cash from Investing Activities plummeted by 807817.36% in 2020 and then skyrocketed by 8826.95% in 2022.
  • Nutex Health's Cash from Investing Activities (Annual) stood at -$61.2 million in 2020, then soared by 39.57% to -$37.0 million in 2021, then surged by 88.27% to -$4.3 million in 2022, then plummeted by 159.14% to -$11.2 million in 2023, then skyrocketed by 50.12% to -$5.6 million in 2024.
  • Its Cash from Investing Activities stands at -$5.6 million for FY2024, versus -$11.2 million for FY2023 and -$4.3 million for FY2022.